CoChat

Expression site of P2RY12 in residential microglial cells in astrocytomas correlates with M1 and M2 marker expression and tumor grade

Open access
Zhu, Changbin, Kros, Johan M., van der Weiden, Marcel, Zheng, PingPin, Cheng, Caroline, Mustafa, Dana A. M. · 2017 · Acta Neuropathologica Communications

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

The role of resident microglial cells in the pathogenesis and progression of glial tumors is still obscure mainly due to a lack of specific markers. Recently P2RY12, a P2 purinergic receptor, was introduced as a specific marker for microglial cells under normal and pathologic conditions. Here we analyzed the expression of P2RY12 in astrocytomas of various malignancy grades in relation to markers for M1 and M2 macrophage activation profiles by using two web-based glioma datasets and confocal immunohistochemistry to 28 astrocytoma samples grades II-IV. In the gliomas, P2RY12 immunoreactivity delineated CD68 negative cells with otherwise microglial features from CD68 positive tumor associated macrophages (TAMs). The presence of P2RY12 positive cells correlated positively with overall survival. P2RY12 mRNA levels and membrane-bound localization of P2RY12 were inversely correlated with increasing malignancy grade, and the expression site of P2RY12 shifted from cytoplasmic in low-grade gliomas, to nuclear in high-grade tumors. The cytoplasmic expression of P2RY12 was associated with the expression of M1 markers, characteristic of the pro-inflammatory macrophage response. In contrast, the nuclear localization of P2RY12 was predominant in the higher graded tumors and associated with the expression of the M2 marker CD163.We conclude that P2RY12 is a specific marker for resident microglia in glioma and its expression and localization correspond to tumor grade and predominant stage of M1/M2 immune response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40478-016-0405-5

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Reduced P2RY12 expression and nucleus translocation in microglia/macrophages correlated with glioma progression. a: Analysis of GEO databases reveals decrease of P2RY12 mRNA expression with progression of glioma. Results are shown in the median values of P2RY12 mRNA levels. ** P < 0.01; ***P < 0.005. A II: Astrocytoma WHO grade II, AA: Anaplastic Astrocytoma (WHO grade III), GBM: Glioblastoma. b: Immunohistochemical staining for P2RY12 in normal brain and different grades of glioma. Representative pictures were selected from each group. Cells with the P2RY12 signal localized mainly in the cytoplasm display the classic ramified microglial morphology in autopsy brain, A II and AA. Cells with nuclear location of P2RY12 are mainly observed in GBM samples (scale bar: 100 μm). c: Quantification of percentages of P2RY12 positive areas per image field in autopsy brain, A II and GBM. Mean values of each group are indicated. * P < 0.05, ** P < 0.01 ****P < 0.001. d: Confocal images showing CD68 and P2RY12 staining in tissue samples of liver and kidney (scale bar: 50 μm). e: Confocal images showing the spatial relation between CD68 and P2RY12 positive cells in autopsy brain, A II, AA and GBM (scale bar: 50 μm). f: Confocal images showing no overlap between GFAP and P2RY12 staining in astrocytoma grade II (scale bar: 20 μm)
Fig. 1 Reduced P2RY12 expression and nucleus translocation in microglia/macrophages correlated with glioma progression. a: Analysis of GEO databases reveals decrease of P2RY12 mRNA expression with progression of glioma. Results are shown in the median values of P2RY12 mRNA levels. ** P < 0.01; ***P < 0.005. A II: Astrocytoma WHO grade II, AA: Anaplastic Astrocytoma (WHO grade III), GBM: Glioblastoma. b: Immunohistochemical staining for P2RY12 in normal brain and different grades of glioma. Representative pictures were selected from each group. Cells with the P2RY12 signal localized mainly in the cytoplasm display the classic ramified microglial morphology in autopsy brain, A II and AA. Cells with nuclear location of P2RY12 are mainly observed in GBM samples (scale bar: 100 μm). c: Quantification of percentages of P2RY12 positive areas per image field in autopsy brain, A II and GBM. Mean values of each group are indicated. * P < 0.05, ** P < 0.01 ****P < 0.001. d: Confocal images showing CD68 and P2RY12 staining in tissue samples of liver and kidney (scale bar: 50 μm). e: Confocal images showing the spatial relation between CD68 and P2RY12 positive cells in autopsy brain, A II, AA and GBM (scale bar: 50 μm). f: Confocal images showing no overlap between GFAP and P2RY12 staining in astrocytoma grade II (scale bar: 20 μm)CC BY · PubMed Central
Fig. 2 Cells in high grade glioma expressing P2RY12 in the nuclei are not recruited cells of myeloid origin, but resident microglia. a: Confocal images showing P2RY12 and CD45 signals in A II, AA and GBM. No overlap between these two markers was observed in any of the gliomas (scale bar: 50 μm). b: Confocal images showing CD68 and CD45 signals in AA (scale bars: left image; 50 μm, right panel; 20 μm). c: Confocal images of triple staining for CD68, P2RY12 and CD45 in AA. Left image: Merged overview of triple staining (scale bar: 50 μm). Right image: Merged high magnification of a P2RY12 positive cell (scale bar: 10 μm). d: Panel of single channel images of a P2RY12 positive cell in AA (scale bar: 10 μm). e: Confocal images showing CD68 and CD45 staining in GBM (scale bar: left image; 50 μm, right panel; 20 μm). f: Confocal images showing triple staining for CD68, P2RY12 and CD45 in GBM. Left panel: Merged overview of triple staining (scale bar: 50 μm). Right panel: Merged higher magnification view of P2RY12 positive cells (scale bar: 10 μm). g: Panel of high magnification single channel images of P2RY12 positive cells in GBM (scale bar: 10 μm)
Fig. 2 Cells in high grade glioma expressing P2RY12 in the nuclei are not recruited cells of myeloid origin, but resident microglia. a: Confocal images showing P2RY12 and CD45 signals in A II, AA and GBM. No overlap between these two markers was observed in any of the gliomas (scale bar: 50 μm). b: Confocal images showing CD68 and CD45 signals in AA (scale bars: left image; 50 μm, right panel; 20 μm). c: Confocal images of triple staining for CD68, P2RY12 and CD45 in AA. Left image: Merged overview of triple staining (scale bar: 50 μm). Right image: Merged high magnification of a P2RY12 positive cell (scale bar: 10 μm). d: Panel of single channel images of a P2RY12 positive cell in AA (scale bar: 10 μm). e: Confocal images showing CD68 and CD45 staining in GBM (scale bar: left image; 50 μm, right panel; 20 μm). f: Confocal images showing triple staining for CD68, P2RY12 and CD45 in GBM. Left panel: Merged overview of triple staining (scale bar: 50 μm). Right panel: Merged higher magnification view of P2RY12 positive cells (scale bar: 10 μm). g: Panel of high magnification single channel images of P2RY12 positive cells in GBM (scale bar: 10 μm)CC BY · PubMed Central
Fig. 3 Cytoplasmatic and nuclear distribution of P2RY12 in microglia is correlated with M2-like activation in high grade glioma. a1-a3: Co-expression of cytoplasmic P2RY12 with CD163 and CD204 in AA (scale bar: 200 μm). b1-b3: Overview of AA tissue samples (scale bar: 10 mm). c1-c3: Co-expression of nuclear P2RY12 with CD163 and CD204 in AA (scale bar: 200 μm). d1-d3: Co-expression of cytoplasmic P2RY12 with CD163 and CD204 in GBM (scale bar: 200 μm). e1-e3: Overview of GBM tissue samples (scale bar: 10 mm). f1-f3: Co-expression of nuclear P2RY12 with CD163 and CD204 in GBM (scale bar: 200 μm)
Fig. 3 Cytoplasmatic and nuclear distribution of P2RY12 in microglia is correlated with M2-like activation in high grade glioma. a1-a3: Co-expression of cytoplasmic P2RY12 with CD163 and CD204 in AA (scale bar: 200 μm). b1-b3: Overview of AA tissue samples (scale bar: 10 mm). c1-c3: Co-expression of nuclear P2RY12 with CD163 and CD204 in AA (scale bar: 200 μm). d1-d3: Co-expression of cytoplasmic P2RY12 with CD163 and CD204 in GBM (scale bar: 200 μm). e1-e3: Overview of GBM tissue samples (scale bar: 10 mm). f1-f3: Co-expression of nuclear P2RY12 with CD163 and CD204 in GBM (scale bar: 200 μm)CC BY · PubMed Central
Fig. 4 Confocal analysis of co-localization of P2RY12, CD163 and CD45 in GBM. a: Upper row: overview of immunostaining for P2RY12 and CD163 in a representative GBM. White arrows indicate nuclear P2RY12 signal in cells with high CD163 signal; Cyan arrows indicate cytoplasmic P2RY12 signal in cells with low CD163 signal (scale bar:100 μm). Lower row: selected view of P2RY12 and CD163 staining in glioblastoma. White arrows indicate cells with weak P2RY12 and high CD163 signal (scale bar: 50 μm). Inserts: details of cells with low CD163 and strong cytoplasmic P2RY12 signals, and cells with strong CD163 and weak P2RY12 signals. b: Overview with two inserts. Upper panel: area with cells with nuclear P2RY12 signal with strong CD163 expression (scale bar: 50 μm). Lower panel: area with cytoplasmic P2RY12 signals and weak CD163 expression (scale bar: 50 μm). White arrows: nuclear P2RY12 expression with strong CD163 signals. c: Overview: triple staining for CD163, P2RY12 and CD45 in GBM (scale bar: 50 μm). Inserts (scale bar: 20 μm): Cells with high CD163 and nuclear P2RY12 signals did not overlap with CD45. d: Confocal images showing triple staining for CD163, P2RY12 and CD45 in GBM (scale bar: 20 μm). Cells with high CD163 and nuclear P2RY12 signal did not overlap with CD45
Fig. 4 Confocal analysis of co-localization of P2RY12, CD163 and CD45 in GBM. a: Upper row: overview of immunostaining for P2RY12 and CD163 in a representative GBM. White arrows indicate nuclear P2RY12 signal in cells with high CD163 signal; Cyan arrows indicate cytoplasmic P2RY12 signal in cells with low CD163 signal (scale bar:100 μm). Lower row: selected view of P2RY12 and CD163 staining in glioblastoma. White arrows indicate cells with weak P2RY12 and high CD163 signal (scale bar: 50 μm). Inserts: details of cells with low CD163 and strong cytoplasmic P2RY12 signals, and cells with strong CD163 and weak P2RY12 signals. b: Overview with two inserts. Upper panel: area with cells with nuclear P2RY12 signal with strong CD163 expression (scale bar: 50 μm). Lower panel: area with cytoplasmic P2RY12 signals and weak CD163 expression (scale bar: 50 μm). White arrows: nuclear P2RY12 expression with strong CD163 signals. c: Overview: triple staining for CD163, P2RY12 and CD45 in GBM (scale bar: 50 μm). Inserts (scale bar: 20 μm): Cells with high CD163 and nuclear P2RY12 signals did not overlap with CD45. d: Confocal images showing triple staining for CD163, P2RY12 and CD45 in GBM (scale bar: 20 μm). Cells with high CD163 and nuclear P2RY12 signal did not overlap with CD45CC BY · PubMed Central
Fig. 5 Analysis of TCGA datasets: High expression levels of P2RY12 in GBM patients predict a favorable outcome. a: Kaplan-Meier curves showing disease free survival and overall survival curves of patients with different P2RY12 expression levels. b: Overlap of the genes found in the two datasets that positively correlate with P2RY12 expression. c: Top 20 most significant biological processes resulting from functional annotation of the 222 overlapping genes. The GO terms are shown on the y-axis. The numbers of input genes per GO term are indicated on the x-axis. d: Overlap of the genes found in the two datasets that negatively correlate with P2RY12 expression. e: Top 20 most significant biological processes resulting from functional annotation of the 58 overlapping genes. The GO terms are shown on the y-axis. The numbers of input genes per GO term are indicated on the x-axis
Fig. 5 Analysis of TCGA datasets: High expression levels of P2RY12 in GBM patients predict a favorable outcome. a: Kaplan-Meier curves showing disease free survival and overall survival curves of patients with different P2RY12 expression levels. b: Overlap of the genes found in the two datasets that positively correlate with P2RY12 expression. c: Top 20 most significant biological processes resulting from functional annotation of the 222 overlapping genes. The GO terms are shown on the y-axis. The numbers of input genes per GO term are indicated on the x-axis. d: Overlap of the genes found in the two datasets that negatively correlate with P2RY12 expression. e: Top 20 most significant biological processes resulting from functional annotation of the 58 overlapping genes. The GO terms are shown on the y-axis. The numbers of input genes per GO term are indicated on the x-axisCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Cited by

See all 81

Metadata

Authors
Zhu, C., Kros, J. M., van der Weiden, M., Zheng, P., Cheng, C., & Mustafa, D. A. M.
Affiliations
Erasmus MC (NL)
Corresponding author
Mustafa, Dana A. M.
Venue
Acta Neuropathologica Communications
Published
2017-01-10
Volume
5
Issue
1
Pages
4-4
ISSN
2051-5960 (ISSN-L)
OpenAlex
W2570663248
Cited by
81
References
41
Citations by year
2026: 9 · 2025: 6 · 2024: 8 · 2023: 3 · 2022: 13 · 2021: 12 · 2020: 11 · 2019: 7 · 2018: 9 · 2017: 3
FWCI
4.09
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Acta Neuropathologica Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion)
Funders
  • Chinese Scholarship Council (201206230102)
  • Netherlands Foundation for Cardiovascular Excellence (CVON2014-11 RECONNECT)
  • VIDI grant (91714302)
  • KWF Kankerbestrijding (KWF EMCR 2009-4553)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
Keywords
P2Y12 receptor, astrocytoma, tumor-associated macrophages, M1 macrophages, M2 macrophages, tumor grade, CD163, CD68, purinergic receptors, nuclear localization, overall survival
MeSH terms
CD68 Molecule, Adult, Astrocytoma, Brain, Brain Neoplasms, Cell Nucleus, Cytoplasm, Female, Humans, Immunohistochemistry, Male, Middle Aged, RNA, Messenger, Biomarkers, Tumor, Antigens, Differentiation, Myelomonocytic, Antigens, CD, Gene Expression Regulation, Neoplastic, Survival Analysis, Databases, Factual, Treatment Outcome, Sequence Analysis, RNA, Microglia, Microscopy, Confocal, Neoplasm Grading

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Expression site of P2RY12 in residential microglial cells in astrocytomas correlates with M1 and M2 marker expression and tumor grade. https://app.cochat.ai/papers/10.1186/s40478-016-0405-5
The paper
Zhu, C., Kros, J. M., van der Weiden, M., Zheng, P., Cheng, C., & Mustafa, D. A. M. (2017). Expression site of P2RY12 in residential microglial cells in astrocytomas correlates with M1 and M2 marker expression and tumor grade. Acta Neuropathologica Communications. https://doi.org/10.1186/s40478-016-0405-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.